IP Library Granted Patent US 8,927,723
Granted Patent B2
US 8,927,723 · App. 14/176,334 · Granted Jan 6, 2015

Preparation of pyridonecarboxylic acid antibacterials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,927,723
App. No.
14/176,334
Granted
Jan 6, 2015
Kind
B2
Abstract

A process for making 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, and therapeutically acceptable salts thereof, and intermediates used in the process are disclosed.

Claims (4)

1. A process for making ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-((3-isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-di hydroquinoline-3-carboxylate, or a salt thereof, comprising:

(a) reacting ethyl (2E/Z)-3-((6-amino-3,5-difluoropyridin-2-yl)amino)-2-(2,4,5-trifluorobenzoyl) -2-propenoate, or a salt thereof, lithium chloride and 1,8-diazabicyclo[5.4.0]undec-7-ene and not isolating the product;

(b) reacting the product of step (a), 3-azetidinol hydrochloride and 1,8-diazabicyclo[5.4.0]undec-7-ene and not isolating the product; and

(c) reacting the product of step (b) and isobutyric anhydride and isolating or not isolating the product.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
SECURITY INTEREST Recorded Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2014
From: HAIGHT, ANTHONY; BARNES, DAVID M.; ZHANG, GEOFF G. Z.
To: ABBOTT LABORATORIES
Reel/Frame 033609/0515 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2014
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 033616/0620 →